Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Forschungsstelle

INNOSUISSE

Projektnummer

103.243 IP-LS

Projekttitel

Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Projekttitel Englisch

Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Human medicine
Abstract (Englisch)	Melanoma is the fifth most common cancer in Switzerland and the most lethal skin cancer. NRAS-mutated melanoma is the most aggressive subtype, with no effective therapy after immunotherapy failure. We will develop the first effective targeted therapy combination against this often fatal disease.